🇺🇸 FDA
Pipeline program

Elimusertib (BAY1895344)

18594

Phase 1 small_molecule completed

Quick answer

Elimusertib (BAY1895344) for Advanced Solid Tumor is a Phase 1 program (small_molecule) at Bayer HealthCare AG with 1 ClinicalTrials.gov record(s).

Program details

Company
Bayer HealthCare AG
Indication
Advanced Solid Tumor
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials